Effective Integration of STI & HIV Prevention Programs
|
|
|
- Charles Lindsey
- 10 years ago
- Views:
Transcription
1 Effective Integration of STI & HIV Prevention Programs Jeanne Marrazzo, MD, MPH University of Washington, Seattle September 27, 2013
2 Key Points STIs are really common among those at highest risk of HIV This presents a uniquely focused opportunity to intervene with biobehavioral interventions Comprise evidence-based behavioral & newer biomedical interventions (PrEP, PEP, referral) IAS-USA Guidelines in development; anticipated release early 2014 STI are common and often remain undiagnosed in the HIV care setting
3 Data from 557 adults in a prospective cohort of contemporary HIV-infected adults in primary care in 4 cities Screened/treated for STD at enrollment and at 6 months 13% with STD at enrollment; 7% incident STD at 6 months Excluding trichomoniasis, 94% of incident STDs were in MSM Most common in men: rectal chlamydia, oropharyngeal gonorrhea Risks: polysubstance use, > 4 partners in 6 months 20% of MSM diagnosed with an STD by 6 months: most were asymptomatic Mayer et al. Sex Transm Dis
4 STD Surveillance Network (SSuN) Proportion of MSM* Attending STD Clinics with Primary and Secondary Syphilis, Gonorrhea or Chlamydia by HIV Status, 2010 Percentage HIV HIV P&S syphilis GC urethral GC pharyngeal GC rectal CT urethral CT rectal * MSM = men who have sex with men. HIV negative status includes persons of unknown status for this analysis. GC urethral and CT urethral include results from both urethral and urine specimens. See also Ganesan 2012; Spaulding 2012: military cohort data
5 Barriers to Bacterial STI Screening of HIV+ Men who have Sex with Men in HIV Primary Care Settings Lindley A. Barbee, Shireesha Dhanireddy, Susana Tat, Amy Radford, Jeanne M. Marrazzo ISSTDR 2013 Vienna, Austria
6 Background CDC-funded initiative to increase bacterial STI screening among HIV+ MSM Seattle STD/HIV Prevention Training Center Madison Clinic HIV Primary Care Clinic 2,570 patients 81% Men 66% MSM University of Washington Ryan White Funded
7 Objectives 1) Quantify current STI testing coverage among MSM at Madison Clinic 2) Identify patient and provider related barriers to STI screening
8 Results: STI Testing Coverage 72% Syphilis serology 40% Urine GC/CT NAAT 1,456 MSM March 2011 September % Throat GC (culture or NAAT) 29% Rectal GC/CT (culture or NAAT)
9 Methods: Patient Barriers Anonymous written survey Offered to all male patients in waiting room Over 3 week period in May HIV+ MSM responded
10 Results: Patient Survey (N=110) In the past two months: 69% sexually active in last 2 months Median of 1 sex partner (range 1-20) In the past 12 months: 16.4% methamphetamines use or IVDU 25.5% bacterial STI
11 Results: Care Seeking Choices (N=110) 28% seek STI care outside of HIV Primary Care 50% Why MSM Seek STD Testing Outside of HIV Primary Care 40% 30% 20% 10% 0% 42% 21% 16% "Easier" Anonymity More Frequent N=31 <3% <3% Cost Convenience
12 Methods: Provider Barriers Anonymous electronic survey All HIV care providers Residents, Fellows, Attending Physicians, ARNPs 28 / 33 (85%) responded 23 /28 (82%) attending physicians
13 Results: Provider Knowledge Barriers(n=28) 25% unaware of NAAT for extra-genital GC/CT 32% unsure of CDC STI screening guidelines 25% incorrectly identified the CDC recommended two-drug therapy when presented with a case of pharyngeal gonorrhea
14 Provider Reported Barriers to Routine STI Screening 80% 70% 60% 50% 40% 30% 68% 39% Of those reporting Patient Reluctance: 55% unprepared 82% test elsewhere 27% prefer same-sex provider 20% 21% 10% 0% Lack of time Patient reluctance Uncomfortable w sexual history/exam 7% 7% Unsure of how to collect specimens Lack of support (staff)
15 Results: Provider Suggestions for Improvement 82% tracking system 71% access to results from STD Clinic 57% self-collected specimens 32% individualized QI reports
16 Summary High-risk sexual activity is common among HIV+ MSM engaged in care Comprehensive STI screening remains low in HIV primary care Patients want easy, convenient and anonymous testing Many providers lack STI testing and treatment knowledge, are uncomfortable with sexual history & genital exam, and most are pressed for time.
17 Interventions to Overcome Barriers Provider Education Linkage to STD Clinic Results STI Self-Testing Program
18 STI Self-Testing Program 75 tested in first 3 months Complete testing data on MSM with at least one STD (24.5%) 6 pharyngeal GC (13%) 5 rectal GC (12%) 4 syphilis (11%) 3 rectal CT (7%)
19 Population-based HIV Incidence among Men Diagnosed with Infectious Syphilis, (Pathela et al) Objective: measure HIV incidence after P/S Σ Cases reported to HIV and STD surveillance registries were matched using a deterministic algorithm Measured annual HIV incidence among men following P&S syphilis diagnoses between January 2000-June 2010 Excluded men with known HIV at time of syphilis diagnosis, or within 60 days after Estimates for risk of new HIV diagnosis by key characteristics
20 Study Population White Black Hispanic Other MSM MSW Other risk Syphilis only Concurrent STD* Subsequent STD* Percent of Syphilis Cases * Includes diagnoses of chlamydia, gonorrhea, and lymphogranuloma venereum
21 Follow-up for HIV 2,805 men with syphilis contributed 11,714 person-years of follow-up 423 (15.1%) subsequently acquired HIV Median time to HIV diagnosis was 582 days (range )
22 Results HIV incidence P&S syphilis cases Newly diagnosed HIV Personyears at risk Annual HIV incidence (%) 95% CI (HIV incidence) Total Age Race/ethnicity White Black Hispanic Other
23 Results - HIV incidence P&S syphilis cases Newly diagnosed HIV Personyears at risk Annual HIV incidence (%) 95% CI (HIV incidence) Sexual behavior/risk MSM MSW Other, IDU, or unk Syphilis stage Primary Secondary Bacterial infections Syphilis only Syphilis w/concurrent STD* Syphilis &
24 Implications On a population level, one in 20 NYC MSM with syphilis are diagnosed with HIV within a year Not likely much different from most urban settings currently experiencing syphilis epidemics in MSM Frequent HIV testing to detect AHI and HIV pre-exposure prophylaxis should be considered for HIV-negative syphilis cases
2011 STI Annual Report
STI Annual Report Howard Brown Health Center s third Annual STI Report details sexually transmitted infection (STI) and human immunodeficiency virus (HIV) testing and behavioral trends at many of Howard
2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential. STD Treatment Guidelines. How are the guidelines prepared?
2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential Bradley Stoner, MD, PhD Associate Professor, Washington University School of Medicine Medical Director, St. Louis STD/HIV
Clinical Infectious Diseases Advance Access published September 1, 2015
Clinical Infectious Diseases Advance Access published September 1, 2015 1 No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting Jonathan E. Volk 1, Julia
There s an App for That: An Innovative Tablet-Based Sexual Health Application. Ashley Scarborough, MPH Linda Creegan MS, FNP
There s an App for That: An Innovative Tablet-Based Sexual Health Application Ashley Scarborough, MPH Linda Creegan MS, FNP Disclosure We have no financial interests to disclose Objectives Describe need
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships
HPTN 073: Black MSM Open-Label PrEP Demonstration Project
HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)
Providing Optimal Care for Your MSM Patients
Providing Optimal Care for Your MSM Patients Medical providers have a critical role to play in improving the health outcomes of Black and Latino men who have sex with men (BLMSM). Studies reinforce the
Estimates of New HIV Infections in the United States
Estimates of New HIV Infections in the United States Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new HIV infections has historically
Project AWARE Study Overview. Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD
Project AWARE Study Overview Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD January 9, 2012 Two Testing Strategies Evaluated in 2-arm RCT On-site HIV rapid testing (via fingerstick) with brief participant-tailored
DC Comprehensive HIV Prevention Plan for 2012-2015: Goals and Objectives
DC Comprehensive HIV Prevention Plan for 2012-2015: Goals and Objectives The Comprehensive Plan includes program goals and objectives, monitoring and evaluation, and capacity building activities specific
HIV Epidemiology in New York State
HIV Epidemiology in New York State Lou Smith, MD, MPH Director, Division of Epidemiology, Evaluation and Research AIDS Institute, New York State Department of Health 2 HIV Surveillance in New York State
CDC 2015 STD Treatment Guidelines: What s new?
: What s new? Ellen Opie, RN/FNP, MPH Guest Faculty, CaliforniaPreventionTraining Center Staff, San FranciscoCity Clinic (DPH) Disclosure Information Ellen Opie, RN/FNP MPH I have no financial relationships
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Anna Satcher Johnson, MPH Symposium on Measuring the HIV Care Continuum Center for AIDS Research University of Washington
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually
Men Who Have Sex With Men Have a 140-Fold Higher Risk for Newly Diagnosed HIV and Syphilis Compared With Heterosexual Men in New York City
EPIDEMIOLOGY AND PREVENTION Men Who Have Sex With Men Have a 140-Fold Higher Risk for Newly Diagnosed HIV and Syphilis Compared With Heterosexual Men in New York City Preeti Pathela, DrPH, MPH,* Sarah
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of
TREATMENT OF STI CONTACTS
This decision support tool is effective as of October 2014. For more information or to provide feedback on this or any other decision support tool, email [email protected] TREATMENT OF STI CONTACTS
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
Slide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know. Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know.
Slide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know. This is a presentation for healthcare providers about
Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011
Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011 Table of Contents Purpose..3 Overview of HIV Health Care.....4 Goal 1: Reducing the Number of People who become infected
STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT
STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT RELEASE DATE: REVIEW INTERVAL: YEARLY REVIEW DATE: SITE/SERVICE UNIT: IMPLEMENTATION DATE: REVIEWED BY: CONTACT: APPROVED BY: CONTENTS
California Guidelines for STD Screening and Treatment in Pregnancy
California Guidelines for STD Screening and Treatment in Pregnancy These guidelines were developed by the California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch
Understanding the HIV Care Continuum
Understanding the HIV Care Continuum Overview Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the health of people living with HIV, but also dramatically lowers
Guidelines for Preventative Health Care in LGBT Populations
+ Guidelines for Preventative Health Care in LGBT Populations Katie Imborek, MD Department of Family Medicine Co-Director UI LGBTQ Clinic April 2 nd, 2014 + Objectives n Understand CDC screening guidelines
EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO
EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO R Eavou, M Taylor, C Bertozzi-Villa, D Amarathithada, R Buffington, D Pitrak and N Benbow HIV Prevention
Developed by: California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch. In collaboration with:
Best Practices for the Prevention and Early Detection of Repeat Chlamydial and Gonococcal Infections: Effective Partner Treatment and Patient Retesting Strategies for Implementation in California Health
Rhode Island Department of Health Division of Infectious Diseases and Epidemiology
Rhode Island Department of Health Division of Infectious Diseases and Epidemiology STD (Sexually Transmitted Disease) PROGRAM Expedited Partner Therapy (EPT) for STDs Guidance for Medical Providers in
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013
Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013 On July 16, 2012, the Food and Drug Administration (FDA) approved
Correlates of not receiving HIV care among HIV-infected women enrolling in a HRSA SPNS multi-site initiative
Correlates of not receiving HIV care among HIV-infected women enrolling in a HRSA SPNS multi-site initiative Oni J. Blackstock, MD, MHS Assistant Professor of Medicine Division of General Internal Medicine
GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)
Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN
2012 2014 Maryland HIV Plan
Maryland Department of Health & Mental Hygiene Prevention and Health Promotion Administration 2012 2014 Maryland HIV Plan Comprehensive HIV Plan Statewide Coordinated Statement of Need Maryland HIV Prevention
HIV Surveillance Update
HIV Surveillance Update Presentation to: CAPUS Metro Atlanta Testing and Linking Consortium (MATLC) Presented by: Deepali Rane, MPH and Jane Kelly, MD Georgia Department of Public Health Epidemiology Date:
2014-2016 ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN
2014-2016 ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN JULY 2014 Prepared by the Oakland TGA Collaborative Community Planning Council HIV Prevention Committee & the Alameda County Office
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...
Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers
Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers James Wilton Coordinator, Biomedical Science of HIV Prevention
CME Article Hiv Disease Surveillance
CME Article Hiv Disease Surveillance hiv disease surveillance cme Collaboration between Medicine and Public Health Sindy M. Paul, md, mph; Helene Cross, phd; Linda Dimasi, mpa; Abdel R. Ibrahim, phd; and
Getting to Know PrEP (Pre-Exposure Prophylaxis)
(Pre-Exposure Prophylaxis) What is PrEP? Prep stands for Pre-Exposure Prophylaxis: a medication that was recently approved by the FDA for daily use that can help high-risk patients who are HIV negative
HIV/AIDS in the Houston Area
HIV/AIDS in the Houston Area The 2013 Houston Area Integrated Epidemiologic Profile for HIV/AIDS Prevention and Care Services Planning Page 1 Disclaimer: This document is the most current HIV/AIDS epidemiologic
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral
Frequently Asked Questions
Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).
Chlamydia trachomatis genital infection is the
CME Activity Inside and Online CHLAMYDIA TESTING AND TREATMENT Take a sexual history of all patients, including adolescents anyone who is sexually active is at risk for chlamydia infection. Screen sexually
Provincial Infectious Diseases Advisory Committee (PIDAC)
Provincial Infectious Diseases Advisory Committee (PIDAC) Sexually Transmitted Infections Case Management and Contact Tracing Best Practice Recommendations Ministry of Health and Long-Term Care Published
HIV Guidelines. New Strategies.
HIV Guidelines. New Strategies. Santiago Moreno Hospital Universitario Ramón y Cajal Madrid HIV Guidelines. New Strategies. Outline HIV Guidelines What is new? New strategies Treatment as Prevention HIV
STI case management. Francis Ndowa - GFMER Theodora Wi - WHO
Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care STI case management Francis Ndowa - GFMER Theodora
Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report
ATTACHMENT B Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, Interim Progress Report Overall HIV Indicator A.1: The number of newly diagnosed HIV infections Original
2010 STD Treatment Guidelines: Update for Primary Care Providers
2010 STD Treatment Guidelines: Update for Primary Care Providers Sharon Adler, MD MPH STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Overview CDC
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Age Differences in Viral Suppression, Antiretroviral Therapy Use, and Adherence Among HIV-positive Men Who Have Sex With Men Receiving
Exploring Cost and Delivery of STI Services by Health Departments in Georgia: A Mixed Methods Approach
PHSSR Research-In-Progress Series: Quality, Cost and Value of Public Health Services Thursday, May 21, 2015 1:00-2:00 pm ET Exploring Cost and Delivery of STI Services by Health Departments in Georgia:
Emerging Issues in Sexually Transmitted Diseases. Webinar. Managing STDs in Correctional Settings: Behind the Walls
Emerging Issues in Sexually Transmitted Diseases Webinar Managing STDs in Correctional Settings: Behind the Walls Please listen to the webinar on your computer using speakers or a headset. We will compile
Benjamin Tsoi, MD, MPH Director of HIV Diagnostics Bureau of HIV/AIDS Prevention and Control NYC Department of Health & Mental Hygiene
Benjamin Tsoi, MD, MPH Director of HIV Diagnostics Bureau of HIV/AIDS Prevention and Control NYC Department of Health & Mental Hygiene Integrated Sexual Health Services Program Collaboration & Service
Partner Notification and Management Interventions
Ch07.qxd 3/5/07 10:47 AM Page 170 7 Partner Notification and Management Interventions Matthew Hogben, Ph.D., Devon D. Brewer, Ph.D., and Matthew R. Golden, M.D., M.P.H. Partner notification (PN) for STDs
COMMUNICABLE DISEASE
Public Health Activities & Services Inventory Technical Notes COMMUNICABLE DISEASE CLINICAL SERVICES, SURVEILLANCE AND CONTROL In 2014, decision was made to adopt number of national public health activities
HIV Prevention Through Early Detection and Treatment of Other Sexually Transmitted Diseases United States
July 31, 1998 / Vol. 47 / No. RR-12 TM Recommendations and Reports HIV Prevention Through Early Detection and Treatment of Other Sexually Transmitted Diseases United States Recommendations of the Advisory
Pre-exposure prophylaxis (PrEP)
FACTSHEET Pre-exposure prophylaxis (PrEP) Summary Pre-exposure prophylaxis, or PrEP, is a way for an HIV-negative person who is at risk of HIV infection to reduce their risk of becoming infected with HIV.
Perspective Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold?
Perspective Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold? There are numerous aspects of the Patient Protection and
2013 STD/HIV Surveillance Report
213 STD/HIV Surveillance Report State of Louisiana Department of Health and Hospitals Office of Public Health Louisiana Department of Health and Hospitals Office of Public Health STD/HIV Program 145 Poydras
Illustrating HIV/AIDS in the United States
Illustrating HIV/AIDS in the United States Black Persons 2013 Update About AIDSVu AIDSVu is a compilation of interactive, online maps that allows users to visually explore the HIV epidemic in the U.S.
EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA
EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE PLANNING, PHILADELPHIA ELIGIBLE METROPOLITAN AREA 2015 Prepared for the Philadelphia Eligible Metropolitan Area Ryan
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually
Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS
Targeted HIV Testing & Enhanced Testing Technologies HIV Prevention Section Bureau of HIV/AIDS May 2012 1 Typing a Question in the Chat Box Type question in here 2 Completing the Webinar Evaluation (opened
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML) George Yaghmour, MD Hematology Oncology Fellow PGY5 UTHSC/West cancer Center, Memphis, TN May,1st,2015 Off-Label Use Disclosure(s) I do not intend
Outpatient/Ambulatory Health Services
Outpatient/Ambulatory Health Services Service Definition Outpatient/ambulatory medical care includes the provision of professional diagnostic and therapeutic services rendered by a physician, physician
SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS
SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS Take history:- History of presenting problem Full sexual history (refer to guideline on sexual history taking) Relevant past medical history, including previous
Condoms for the prevention of HIV and STI transmission
FACTSHEET Condoms for the prevention of HIV and STI transmission Summary Condoms are physical barriers that can reduce the risk of a sexual exposure to HIV and sexually transmitted infections (STIs). They
2014 2015 STD Treatment Guidelines What s New?
2014 2015 STD Treatment Guidelines What s New? Kees Rietmeijer Medical Director Denver STD Prevention Training Center Source: www.denverptc.org Source:NNPTC The More Things Change. Source: NNPTC The More
GAO INDIAN HEALTH SERVICE. HIV/AIDS Prevention and Treatment Services for American Indians and Alaska Natives. Report to Congressional Requesters
GAO United States Government Accountability Office Report to Congressional Requesters December 2007 INDIAN HEALTH SERVICE HIV/AIDS Prevention and Treatment Services for American Indians and Alaska Natives
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE
HIV Continuum of Care Monitoring Framework 2014
HIV Continuum of Care Monitoring Framework 2014 Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean HIV Continuum of Care Monitoring Framework
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG Tx CENTERS Tuberculosis Control Program Health and Human Services Agency San Diego County INTRODUCTION Reducing TB disease requires
